Patents by Inventor Paul Andrew BASCIANO

Paul Andrew BASCIANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240101666
    Abstract: The disclosure provides a method of treating a human subject afflicted with lung cancer with a lymphocyte activation gene-3 (LAG-3) antagonist. In some aspects, the method comprises combination of the LAG-3 antagonist with an additional therapeutic agent (e.g., a programmed death-1 pathway inhibitor) and/or anti-cancer therapy (e.g., chemotherapy such as a platinum doublet chemotherapy).
    Type: Application
    Filed: October 22, 2021
    Publication date: March 28, 2024
    Applicant: Bristol-Myers Squibb Company
    Inventors: Laurence David TOMS, Paul Andrew BASCIANO
  • Patent number: 11351163
    Abstract: The disclosure is directed to methods of treating cancer in subjects with a combination of a monoclonal antibody and (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide, or a salt thereof.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: June 7, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventors: Paul Andrew Basciano, Justine Kamilah Walker, Penny E. Phillips, Li Zhu, Steven H. Bernstein, James Cassidy, Katy Lynn Simonsen, Alexander Azrilevich, Shivani Srivastava
  • Publication number: 20210030739
    Abstract: The disclosure is directed to methods of treating cancer in subjects with a combination of a monoclonal antibody and (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide, or a salt thereof.
    Type: Application
    Filed: September 28, 2018
    Publication date: February 4, 2021
    Inventors: Paul Andrew BASCIANO, Justine Kamilah WALKER, Penny E. PHILLIPS, Li ZHU, Steven H. BERNSTEIN, James CASSIDY, Katy Lynn SIMONSEN, Alexander AZRILEVICH, Shivani SRIVASTAVA